Symposium 3: Fasting plasma glucose, HbA1c or oral glucose tolerance test: should we use the three tests to evaluate the patient?

Authors

  • Isaac Sinay Cardiovascular Institute of Buenos Aires, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/diab.v56i3Sup.496

Keywords:

diabetes mellitus

Abstract

The objective of the presentation will be to answer , based on some evidences,referred to the eventual additive contributions of the three tests with Progession to Diabetes (PDMT2) and/or exposure to Cardiovascular Risk (CVR) or Chronic Renal Disease (CRD) and how we can use them from a clinical perspective.

In prediabetes definition there are no discrepancias regarding to Impaired Glucose Tolerance (IGT), but they are obvious regarding Impaired Fasting Glucose (IFG) = American Diabetes Association criteria : 100-125 mg/dl an World Health Organization : 110-125 mg/dl. There no agreement also for “intermediate” HbA1c cutoffs = (HbA1c(5.7-6.4%)) for American Diabetes Association and (HbA1c(6.1-6.4%)) in UK (NICE). These divergences have different risk of progression and also the pathophysiological contributions of each of the evaluations could be complementary.

Author Biography

Isaac Sinay, Cardiovascular Institute of Buenos Aires, Autonomous City of Buenos Aires, Argentina

Endocrinologist

References

I. Richter B. Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia. Cochrane Database of Systematic Reviews 2018;10 (10)CD012661.

II. Menke A. Diabetes based on 2-h plasma glucose among those classified as having prediabetes based on fasting plasma glucose or A1c. Diabetes & Vascular Disease Research 2018;15;46-54.

III. Xiaoyan C. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ 2020;370:m2297.

IV. Diurlin S. Persisting prediabetic conditions and glomerular filtration rate. A longitudinal study. Primary Care Diabetes 2022. doi: 10.1016/j.pcd.2022.05.013.

V. Sinha A, et al. Association of fasting glucose with lifetime risk of incident heart failure: the Lifetime Risk Pooling Project. Cardiovasc Diabetol 2021;20(1):66.

Published

2022-09-01

How to Cite

Sinay, I. (2022). Symposium 3: Fasting plasma glucose, HbA1c or oral glucose tolerance test: should we use the three tests to evaluate the patient?. Journal of the Argentine Society of Diabetes, 56(3Sup), 11–11. https://doi.org/10.47196/diab.v56i3Sup.496

Similar Articles

<< < 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 > >> 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)